U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8 - K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 22, 1997
BSD MEDICAL CORPORATION
Commission file number 0-10783
DELAWARE 75-1590407
(State of Incorporation) (IRS Employer Identification Number)
2188 West 2200 South
Salt Lake City, Utah 84119
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (801) 972-5555
<PAGE>
CURRENT EVENTS ON FORM 8-K
ITEM 5. OTHER EVENTS
On January 6, 1998, BSD Medical Corporation issued an attached
press release regarding a court ruling in litigation with
Urologix, Inc.
On January 13, 1998, BSD Medical Corporation issued an
attached press release regarding appointment of Dr. Michael
Nobel to BSD's Board of Directors.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits:
No exhibits are being filed with this Form 8-K.
<PAGE>
Contact: Dixie Toolson Sells
BSD MEDICAL CORPORATION
Telephone: (801) 972-5555
Email: [email protected]
For Immediate Release
- ---------------------
BSD Medical Announces Significant Court Ruling
in License Litigation with Urologix, Inc.
Court Grants BSD's Motion for Partial Summary Judgment in
Urologix Litigation
SALT LAKE CITY, Utah, January 6, 1998 - BSD Medical (OTCBB:BSDM)
On December 22, 1997, the United States District Court for
the District of Minnesota issued a significant ruling in the
litigation between BSD Medical Corporation (BSD) and Urologix,
Inc. The litigation concerns the continued validity of the non-
exclusive license to practice certain patents granted by BSD to
Urologix in settlement of prior patent infringement litigation.
In its counterclaim against Urologix, BSD alleged that Urologix
breached a confidentiality provision of the license agreement
and that the Company's termination of the license agreement was
therefore proper. In ruling on the parties' cross-motions for
summary judgment, the District Court denied Urologix's motion
and granted BSD's motion, finding that Urologix had breached
the technology license agreement.
BSD pioneered the commercial field of heat therapy for the
treatment of disease and the non-surgical treatment of benign
diseases of the prostate using microwave energy. BSD Medical
Corporation is the leading developer and manufacturer of
hyperthermia systems for cancer therapy.
Statements contained in this press release which are not
historical facts are forward looking statements as that item is
defined in the Private Securities Litigation Reform Act of
1995. Such forward-looking statements are subject to risks and
uncertainties which could cause actual results to differ
materially from estimated results. Such risks and
uncertainties are detailed in the Company's filings with the
Securities and Exchange Commission.
<PAGE>
Contact: Dixie Toolson Sells
BSD MEDICAL CORPORATION
Telephone: (801) 972-5555
Email: [email protected]
For Immediate Release
- ---------------------
Dr. Michael Nobel Joins BSD's Board of Directors
Nobel Family Chairman Accepts Nomination as BSD Director
SALT LAKE CITY, Utah, January 13, 1998 - BSD Medical (OTCBB:BSDM)
BSD Medical announced today that Dr. Michael Nobel has accepted
a position as a member of the Board of Directors. Dr. Nobel
brings a wealth of experience from a distinguished life and
career to his position as BSD director. Dr. Gerhard Sennewald,
a BSD director, stated that, "Dr. Nobel brings to the BSD Board
invaluable experience and will provide an important and
distinctive perspective to the planning for the future of BSD
because of his comprehensive understanding of the healthcare
industry. We are very proud to have him join the Board of
Directors and look forward to his contributions to the
Company."
Dr. Nobel is the Chairman of the Board of the Nobel Family
Society and is a great-grandnephew of Alfred Nobel. He has
served as a consultant to Unesco in Paris and the United
Nations Social Affairs Division in Geneva and is Chairman of
the American Non-Violence Project Inc.
Following studies in Sweden and the U.S. (Harvard Business
School), Dr. Nobel obtained a doctorate from the University of
Lausanne, Stockholm. Dr. Nobel is currently CEO of the MRAB
group, which provides diagnostic imaging services, and is
either chairman or a member of the board of five international
companies involved in medical diagnostics and treatment. He
participated in the introduction of magnetic resonance imaging
(as European Vice President for Fonar Corp.) and has worked in
that field since 1980.
BSD pioneered the commercial field of heat therapy for the
treatment of disease and the non-surgical treatment of benign
diseases of the prostate using microwave energy. BSD Medical
Corporation is the leading developer and manufacturer of
hyperthermia systems for cancer therapy.
Statements contained in this press release which are not
historical facts are forward looking statements as that item is
defined in the Private Securities Litigation Reform Act of
1995. Such forward-looking statements are subject to risks and
uncertainties which could cause actual results to differ
materially from estimated results. Such risks and
uncertainties are detailed in the Company's filings with the
Securities and Exchange Commission.
######
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.
BSD MEDICAL CORPORATION
Date: January 14, 1998 By: /s/ Paul F. Turner
Paul F. Turner
Chairman of the Board, Acting
President, and Senior Vice
President of Research
